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Abstract
Introduction Laparoscopic antireflux surgery (LARS) in
children primarily aims to decrease reflux events and
reduce reflux symptoms in children with therapy-resistant
gastroesophageal reflux disease (GERD). The aim was to
objectively assess the effect and efficacy of LARS in
pediatric GERD patients and to identify parameters asso-
ciated with failure of LARS.
Methods Twenty-five children with GERD [12 males,
median age 6 (2–18) years] were included prospectively.
Reflux-specific questionnaires, stationary manometry, 24-h
multichannel intraluminal impedance pH monitoring (MII-
pH monitoring) and a 13C-labeled Na-octanoate breath test
were used for clinical assessment before and 3 months
after LARS.
Results After LARS, three of 25 patients had persisting/
recurrent reflux symptoms (one also had persistent
pathological acid exposure on MII-pH monitoring). New-
onset dysphagia was present in three patients after LARS.
Total acid exposure time (AET) (8.5–0.8 %; p\ 0.0001)
and total number of reflux episodes (p\ 0.001) signifi-
cantly decreased and lower esophageal sphincter (LES)
resting pressure significantly increased (10–24 mmHg,
p\ 0.0001) after LARS. LES relaxation, peristaltic con-
tractions and gastric emptying time did not change. The
total number of reflux episodes on MII-pH monitoring
before LARS was a significant predictor for the effect of
the procedure on reflux reduction (p\ 0.0001).
Conclusions In children with therapy-resistant GERD,
LARS significantly reduces reflux symptoms, total acid
exposure time (AET) and number of acidic as well as
weakly acidic reflux episodes. LES resting pressure
increases after LARS, but esophageal function and gastric
emptying are not affected. LARS showed better reflux
reduction in children with a higher number of reflux epi-
sodes on preoperative MII-pH monitoring.
Keywords Pediatric  Children  Reflux  GERD 
Fundoplication  Efficacy
Gastroesophageal reflux disease (GERD) frequently occurs
in the pediatric population [1, 2]. In severe GERD resistant to
medical treatment, laparoscopic antireflux surgery (LARS)
can be warranted [2–4]. Many studies have been published
on pediatric LARS [5–12]. Most of these studies had a ret-
rospective design and could only conclude that the procedure
resulted in symptom control in 57–100 % of patients
[11, 13, 14]. To assess the efficacy of LARS, it is important to
use validated questionnaires before and after LARS. Such
questionnaires, however, have not been used in the majority
of pediatric LARS studies [15]. In addition to evaluation of
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reflux symptoms, more objective assessments of (acid)
reflux, such as multichannel intraluminal impedance pH
(MII-pH) monitoring, should be performed [9, 10, 16].
In previous published pediatric studies, objective
assessments were primarily performed using only pH
monitoring [6, 9, 10, 12]. MII-pH monitoring enables
quantification of both acid and weakly acidic reflux and the
proximal extent of the refluxate [17] and therefore increa-
ses the yield of symptom association assessments in chil-
dren [18]. Studies in children using MII in addition to pH
monitoring so far either were retrospective [19] or only
investigated efficacy in a selected patient population [20].
However, up to now none of the studies quantifying both
reflux symptoms and more objective assessments of GERD
after LARS have shown a correlation between both mea-
surements [9, 10]. It is therefore important to evaluate
effects and efficacy of LARS using both validated ques-
tionnaires and objective assessment tools.
The success of LARS is determined by the disappearance
or reduction of GERD, but is also influenced by postopera-
tive sequelae, such as severe dysphagia and gas/bloating
[21]. It is therefore indicated to identify predictors for failure
in order to enable optimal preoperative counseling on the risk
of persisting or recurrent GERD after LARS. Rosen et al.
[19] addressed this issue in a retrospective study by trying to
identify predictors for failure of LARS in children using
preoperativeMII-pHmonitoring in 37 patients. However, no
predictors could be identified in this study.
The aim of the current prospective study was to objec-
tively assess the effect and efficacy of LARS in pediatric
patients and to identify predictors of LARS failure.
Methods
We performed a prospective multicenter study in three
University Medical Centers in the Netherlands that are
specialized in performing laparoscopic fundoplication in
children (Wilhelmina Children’s Hospital, University
Medical Center Utrecht (UMCU); Sophia’s Children’s
Hospital, Erasmus University Medical Center (Erasmus
MC) and Maastricht University Medical Center (MUMC).
From July 2011 to December 2013 we prospectively
included all pediatric patients diagnosed with PPI therapy-
resistant GERD. Patients who underwent any previous
esophageal or gastric surgery (except previous gastrostomy
placement) and those with structural abnormalities other
than an esophageal hiatal hernia were excluded.
Surgical procedures
All laparoscopic fundoplication procedures were per-
formed by experienced pediatric surgeons. In the UMCU
Utrecht, the anterior, partial fundoplication according to
Thal [22] was used to perform fundoplication. In the other
two UMCs (EMC and MUMC), the posterior, total fun-
doplication according to Nissen [23] was performed.
Before fundoplication, the distal esophagus was fully
mobilized; the distal 3 cm of the esophagus was reposi-
tioned back into the abdomen. Both vagal nerves were
identified, and a crusplasty was performed routinely
(UMCU and EMC). Thereafter, the fundoplication was
constructed. The Thal fundoplication was performed by
plicating the fundus of the stomach over 270 against the
distal anterior intra-abdominal part of the esophagus and
the diaphragmatic crus [9, 22]. A floppy Nissen was con-
structed with one of the sutures of the 360 degrees posterior
wrap incorporated in the esophageal wall [23].
Clinical assessment
Before and 3 months after laparoscopic fundoplication,
clinical assessment was performed using stationary
manometry, 24-h multichannel intraluminal impedance pH
monitoring (MII-pH monitoring), 13C-labeled Na-oc-
tanoate breath test and a reflux-specific symptom ques-
tionnaire. Surgical reinterventions, type and indication for
reintervention, endoscopic procedures, use of antireflux
medication, complications and comorbidities were regis-
tered in a prospective database.
Reflux-specific symptom questionnaires
To assess reflux symptoms, patients and/or their parents
were asked to fill out the validated age-adjusted Gastroe-
sophageal Reflux Symptom Questionnaire (GSQ) before
and after LARS [24]. Reflux symptoms and dysphagia
were scored for frequency and severity on a score ranging
from 1 (none) to 7 (most severe). Symptoms were defined
as no symptoms (no symptoms reported); mild (mild
symptoms weekly); moderate (mild symptoms daily or
severe symptoms weekly) and severe (severe symptoms
daily). Reflux symptoms were scored using the symptoms
heartburn, regurgitation, food refusal and vomiting. Fur-
thermore, the need for acid suppressive therapy after LARS
was registered.
Nutritional status
Weight and height measurements were converted to
weight-for-length and length-for-age z scores based on the
Netherlands Organization for Applied Scientific Research
(TNO) growth standards [25]. Z scores allow comparison
of an individual’s weight or height, adjusting for age and
sex relative to a reference population, expressed in standard
deviations from the reference mean.
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Stationary manometry
For esophageal stationary manometry, age-adjusted sta-
tionary water-perfused sleeve-manometry catheters were
used (Mui Scientific, Mississauga, Ontario, Canada). The
sleeve-manometry catheter was positioned with the sleeve
at the level of the lower esophageal sphincter (LES) using
the pull-through technique. In a semi-recumbent position,
patients received 10 liquid bolus challenges using saline
combined with lemonade (5 ml) in order to study the
manometric response. During the study, data were recorded
on the Stationary Solar Gastro System (Medical Measure-
ment Systems, Enschede, The Netherlands). Manometry
tracings were analyzed for LES resting and nadir pressure,
LES relaxations, number of peristaltic contractions and
peak amplitude of the contractions according to previously
accepted standards [26].
Ambulatory 24-h MII-pH monitoring
Ambulatory 24-h MII-pH testing was conducted after
cessation of all medication that may have an effect on
gastrointestinal motility and acid secretion for at least
3 days. MII-pH monitoring was performed using an age-
adjusted combined impedance pH catheter with six
impedance segments and one ISFET pH electrode
(Unisensor AG, Attikon, Switzerland). The pH electrode
was positioned above the upper border of the manomet-
rically localized lower esophageal sphincter. Impedance
and pH signals were stored on a digital data logger
(Ohmega, Medical Measurement Systems, Enschede, The
Netherlands), using a sampling frequency of 50 Hz.
Patients were instructed to record reflux symptoms, supine
resting periods and meals, including drinks, in a diary and
by marking the symptom using the recording button on
the data logger. The 24-h MII-pH tracings were analyzed
for the number and acidity of reflux episodes according to
previously described definitions [17]. Pathological acid
exposure was defined as total acid exposure time (AET)
C6 %, C9 % in upright and C3 % in the supine body
position [27, 28]. The symptom index (SI) and the
symptom association probability (SAP) were calculated if
patients had experienced symptoms during the measure-
ment [29, 30].
Gastric emptying breath test
To assess gastric emptying (GE) half-time, we used a 13C-
labeled Na-octanoate breath test [31]. Subjects fasted for at
least 6 h before the study. In children[4 years of age, a
solid test meal containing 13C-labeled Na-octanoate was
performed with 375-g pancake containing 45 mg of 13C-
labeled Na-octanoate (a stable isotope).
For younger children or children who were unable to eat
the pancake within 15 min, 100 mg of 13C-labeled Na-
octanoate was added to a liquid formula (infant formula,
full cream milk or chocolate milk). Breath samples were
obtained in duplicate at 15-min intervals during the course
of 4 h (for the liquid test, breath samples were obtained at
5-min intervals during the first 30 min). Hereafter, the ratio
between 12CO2 and
13CO2 content in breath samples was
analyzed with an isotope ratio mass spectrometer. Finally,
three parameters were calculated. Gastric half-emptying
time (GGE-T) was defined as the time when the first half
of the 13C-labeled substrate had been metabolized, that is,
when the cumulative excretion of 13C in the breath was half
the ingested amount. Gastric emptying percentiles (P) were
calculated according to the reference values obtained by
van den Driessche et al. [32]. GE percentiles higher than 75
were considered delayed and above 95 severely delayed.
The gastric emptying coefficient (GEC) reflects a global
index for GE, influenced by both the rate of appearance and
disappearance of 13C in breath.
Sample size calculation
A sample size of 50 patients was calculated based on the
assumption that approximately 20 % of pediatric GERD
patients will fail after LARS. Success of LARS was defined
as: (1) complete symptom relief and normalized MII-pH
monitoring or (2) complete symptom relief and near-nor-
mal MII-pH monitoring or (3) normalized MII-pH moni-
toring combined with a significant improvement of reflux
symptoms (complaints less than moderate/weekly). Using
the logistic regression model according to Frank Harrell
[33], five failures were required to reliably identify a
determinant of failure. Determinant of interest was gastric
emptying and age at time of operation.
Patients
In total 25 children were included in our study. After
enrollment of the 25th patient, the study was stopped
prematurely, because the inclusion rate was lower than
anticipated. Mean age of the included patients was 6 (range
2–18) years at the time of fundoplication (Table 1). Five
children (80 %) had normal neurodevelopment (NN),
while impaired neurodevelopment (NI) was seen in five
children (20 %). Cause of NI is shown in Table 2.
Ethical approval and trial registration
This study was registered at the start of the study in the
Dutch national trial registry (www.trialregister.nl; Identi-
fier: 2934). Ethical approval for this prospective multi-
center study was obtained from the University Medical
Surg Endosc (2017) 31:1101–1110 1103
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Center Utrecht Ethics Committee, and local approval was
obtained by the remaining two participating centers. Prior
to study procedures, informed consent from the patients’
parents and children (C12 years) was obtained.
Statistical analysis
Continuous variables, when symmetric, were expressed as
mean ± standard error. Skewed variables were expressed
as median with interquartile ranges (IQR). For statistical
analysis, we used the paired sample t test or the Wilcoxon
signed-rank test, whenever appropriate. The McNemar–
Bowker test was used to compare groups in case of
nominal outcome measures. Exploratory subgroup analy-
sis for all outcome measures was performed comparing
neurodevelopment and type of fundoplication. The pri-
mary aim was to perform a logistic regression analysis if
sufficient LARS failures were identified. Linear regression
analysis was performed to identify determinants influ-
encing the effect of LARS on reflux control measured by
24-h MII-pH monitoring. Determinant of interest was age
at time of operation, neurodevelopment, type of fundo-
plication, preoperative number of reflux episodes on 24-h
MII-pH monitoring and preoperative gastric emptying
rate. Differences with a p\ 0.05 were considered statis-
tically significant. All analyses were performed using
IBM22.0.0 SPSS statistical package (IBM, Armonk,
NY).
Results
In total 18 Thal and 7 Nissen fundoplications were per-
formed (Fig. 1). In all patients, fundoplication could be
completed by laparoscopy. Perioperative complications
were not observed. Median hospital admission time was 3.0
(2.0–4.5) days (Table 1). In one patient with retching based
on impaired neurodevelopment a redo-fundoplication was
indicated because of severe recurrent reflux (pathological
reflux on 24-h pH monitoring and severe reflux symptoms)
caused by hiatal herniation. Another patient required
emergency gastroscopy to remove a food bolus impacted in
the esophagus 1 day after LARS. In six children temporary
nasogastric tube feeding was required to obtain sufficient
caloric intake. Insufficient caloric intake was caused by
transient dysphagia (n = 4), persistent dysphagia (n = 1)
or rejection of oral feedings without dysphagia (n = 1).
Symptom assessment
All patients and/or parents completed the reflux-specific
symptom questionnaire (Fig. 1). Overall reflux symptoms
significantly decreased after LARS (p = 0.001). In three of
25 (12 %) patients, reflux symptoms persisted (1/3 also had
persistent pathological acid exposure on MII-pH monitor-
ing) (Table 3). The use of acid suppressive medication
decreased from 100 % of all patients preoperatively to
16 % (n = 4) after operation. Analysis in subgroups
comparing children with NI to NN [NN (5 %) vs NI
(40 %); p = 0.099] and Nissen compared to Thal fundo-
plication [Nissen (11 %) vs Thal (17 %); p = 0.597] did
not show significant differences in the presence of GERD
symptoms after LARS.
Moderate-to-severe dysphagia was reported in eight
(32 %) patients before LARS and in seven (28 %) patients
3 months after LARS (p = 0.887) (Table 3). New-onset
dysphagia was seen in three of these seven patients with
dysphagia after LARS. Dysphagia more frequently occur-
red in NI children [NI (80 %) vs NN (15 %); p = 0.012]
after LARS compared to NN patients. Furthermore, there
was a trend showing that children undergoing Nissen
fundoplication had more frequently dysphagia compared to
those undergoing Thal fundoplication [Nissen (57 %) vs
Thal (17 %); p = 0.066].
Nutritional status
Height-for-weight [-0.2 SD (-1.0 to 0.7) to -0.5 SD
(-1.3 to 0.1); p = 0.57] and height-for-age [-0.9 SD
(-1.2 to 0.1) to -1.0 SD (-1.5 to 0.4); p = 0.42] scores
remained similar when comparing preoperative to 3-month
postoperative measurements.
Table 1 Baseline characteristics
(Median; IQR)
Age at time of operation (years) 6.0 (3.0–11.0)
Duration of hospital admission (days) 3.0 (2.0–4.5)
n (%)
Male gender 12 (48.0 %)
Impaired neurodevelopment 5 (20.0 %)
Gastrostomy preoperatively in situ 4 (16.0 %)
Table 2 Impaired neurodevelopment (n = 5)
CHARGE syndrome
Mitochondrial complex II deficiency
Posthypoxic encephalopathy
Congenital rubella infection
Impaired neurodevelopment of unknown origin with autistic
behavior
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Clinical assessment tests
Postoperative manometry, 24-h MII-pH monitoring and
gastric emptying breath test were not performed in two
patients because of parental refusal (Fig. 1). LES resting
pressure significantly increased after fundoplication from
10 mmHg (7–18) to 24 mmHg (17–26), p\ 0.0001. Nadir
LES pressure also significantly increased from 0 mmHg
(0–8) to 3.5 mmHg (0–8) after LARS, p\ 0.0001. Com-
plete LES relaxation, percentage of continued peristaltic
contractions and peak amplitude all remained similar
(Table 4). Subgroup analysis showed no differences com-
paring NI to NN children. Children undergoing Thal
fundoplication had a significantly higher preoperative LES
resting pressure compared to those who underwent Nissen
fundoplication [Thal (14.6 mmHg) vs Nissen (6.5 mmHg);
p = 0.001]; however, after LARS no statistical difference
was found [Thal (22.7 mmHg) vs Nissen (19.8 mmHg);
p = 0.525]. All other manometry outcome measures were
similar when comparing Thal to Nissen fundoplication.
Twenty-four hour MII-pH monitoring showed a signif-
icant decrease in total acid exposure time and number of
reflux episodes (p\ 0.001; Table 4). Acidic, weakly
acidic, liquid and mixed reflux episodes also decreased
significantly (Table 4). In two patients pathological reflux
persisted after LARS, although in one of these patients
Fig. 1 Flowchart of patient
selection and enrollment
Table 3 Symptom assessment
Preoperative (n, %) 3–4 months postoperative (n, %) p value
Reflux symptoms
None 0 (0 %) 17 (68 %) 0.001
Mild 2 (8 %) 5 (20 %)
Moderate 7 (28 %) 2 (8 %)
Severe 16 (64 %) 1 (4 %)
Dysphagia
None 13 (52 %) 15 (60 %) 0.887
Mild 4 (16 %) 3 (12 %)
Moderate 3 (12 %) 3 (12 %)
Severe 5 (20 %) 4 (16 %)
n number of patients, % percentage of patients, p\ 0.05 is considered significant
Surg Endosc (2017) 31:1101–1110 1105
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total acid exposure time (AET) decreased from 32.8 %
(severe pathological) to 9.7 % (near-normal). Subgroup
analysis comparing NI to NN children revealed that pre-
operative acid exposure time and total number of reflux
episodes (RE) before LARS were significantly higher in NI
children [AET: NN (9.5 %) vs NI (19.3 %); p = 0.006 and
RE: NN (91.5) vs NI (181.4); p = 0.002]. After LARS NI
children still had more reflux, although it was not statisti-
cally significant [AET: NN (1.2 %) vs NI (7.2 %);
p = 0.22 and RE: NN (16.6) vs NI (41.8); p = 0.42]. Other
24-h MII-pH outcome measures were similar comparing NI
to NN children. Comparing Thal to Nissen fundoplication
only identified a significant difference in preoperative total
number of reflux episodes on 24-h MII-pH monitoring
[AET: Thal (121.4) vs Nissen (76.7); p = 0.03]; however,
after LARS outcomes were not significantly different
[AET: Thal (25.9) vs Nissen (11.4); p = 0.33).
GE half-time [77 min (0–113) to 56 min (14–103);
p = 0.102] and GE percentiles did not significantly change
after LARS (Table 4). However, looking at a subset of
patients with preoperative delayed (n = 13) or severely
delayed (n = 8) GE, GE half-time [84 min (58–106) to
54.4 min (40.3–87.3); p = 0.023] and GE percentiles [85
(75–95) to 75 (10–85); p = 0.029] improved significantly.
Furthermore, in four patients GE normalized after LARS
(Fig. 2). Subgroup analysis comparing gastric emptying in
NI to NN children and Thal to Nissen fundoplication did
not show any significant differences.
Predictors of LARS failure
After LARS only one patient had persistent reflux symp-
toms and pathological reflux. As only one patient failed
LARS, a logistic regression analysis was therefore not
feasible.
Predictors of the effect of LARS on reflux control
Linear regression analysis identified preoperative reflux
episodes on MII-pH monitoring as a determinant influ-
encing the effect of LARS reflux episodes (esti-
mate = 0.791; p\ 0.0001). Age at the time of operation,
neurodevelopment, type of fundoplication and GE did not
show any significant effect (Table 5).
Table 4 Results of clinical assessment tests
Preoperative (IQR) 3–4 months postoperative (IQR) p value
24-h MII-pH measurement
Total GER episodes 91.5 (8–230) 14 (2–153) \0.0001
Acid GER episodes 61.5 (34.3–93.8) 8 (1–13) \0.0001
Weakly acid GER episodes 23 (10.5–42) 5 (3–11) 0.002
Liquid GER episodes 55.5 (11–153) 10 (2–96) \0.0001
Mixed GER episodes 37.5 (3–176) 3 (0–57) \0.0001
Proximal extend
Z1 (proximal esophagus) 26.5 (14.5–55.3) 2 (0–8) \0.001
Z3 (mid esophagus) 75.5 (64.8–88) 57 (44–71) 0.009
Z5 (distal esophagus) 100 (100–100) 100 (100–100) NA
Total acid exposure (%) 8.5 (2.5–32.8) 0.8 (0–2.8) \0.0001
Longest reflux episode (min) 20.7 (3.4–66.7) 3.8 (0–21.6) \0.0001
SI (%) 75 (18.8–100) 50 (0–100) 0.111
SAP (%) 100 (97.3–100) 93.2 (22.1–98.7) 0.048
Stationary manometry
LES resting pressure (mmHg) 10 (6.5–18) 23.5 (17–26) \0.0001
LES nadir pressure (mmHg) 0 (0–8) 3.5 (0–8) \0.0001
Complete LES relaxation (%) 100 (100–100) 100 (100–100) 0.311
Continued peristaltic contraction (%) 100 (100–100) 100 (100–100) 0.149
Peak amplitude (mmHg) 74 (39–109) 66 (24–139) 0.299
Gastric emptying test
Gastric emptying half-time (min) 76.5 (49.3–89) 56 (47–78) 0.102
Gastric emptying percentile 75 (0–99) 70 (2–99) 0.530
GEC 3.0 (2.5–5.6) 3.6 (2.3–4.7) 0.463
GER gastroesophageal reflux, SI symptom index, SAP symptom association probability, NA not applicable, LES lower esophageal sphincter,
GEC gastric emptying coefficient, IQR interquartile range, p\ 0.05 is considerd significant
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Discussion
In the present study, LARS was successful in 96 % of
children with therapy-resistant GERD according to both
the symptom and clinical response. LARS reduced not only
acidic reflux episodes, but weakly acidic reflux was also
significantly reduced.
Reflux symptoms significantly decreased after LARS,
and in three (12 %) patients reflux symptoms persisted at
3-month follow-up. This short-term success rate is similar
to other prospective studies in pediatric antireflux surgery
[7, 11, 12]. Subgroup analysis showed that the incidence of
persistent or recurrent reflux symptoms was similar after
both Thal and Nissen fundoplication (p = 0.597). A recent
meta-analysis in both adults and children also reported no
differences between partial and complete fundoplication
techniques in reduction of reflux symptoms [34, 35]. It
must be noted that our study was not powered to study the
differences between both techniques and therefore results
may differ in a larger study population.
When comparing reflux symptoms after LARS in chil-
dren with NI to children with NN, we found that reflux
symptoms were present in only 5 % (1/20) of NN patients
versus almost half (40 %; 2/5) of NI children. This dif-
ference was not statistically different possibly because the
current study was not powered to identify differences
between both groups. Before LARS total acid exposure
time and number of reflux episodes were significantly
higher in NI children; however, after LARS no significant
differences were observed. Some authors hypothesized that
NI children may insufficiently benefit from LARS
[5, 36, 37]; however, we found no statistical significant
differences in our study.
Only one of the three patients with persistent reflux
symptoms also had pathological acid exposure on MII-pH
monitoring; conversely, only one of the two (both NI)
patients with pathological reflux had reflux symptoms after
LARS. In the other NI patient, reflux symptoms completely
resolved and 24-h MII-pH monitoring decreased to near-
normal acid exposure. In adults a lack of correlation
between reflux symptoms and objective assessment of the
prevalence of (acid) refluxate in the esophagus has been
reported as well [38, 39]. It is thought that recurrent or
persistent symptoms may be caused by concomitant func-
tional disease such as functional dyspepsia or hypersensi-
tivity [39]. Moreover, in NI patients symptom assessment
may be even more challenging because NI children are
frequently verbally restricted and often have more (co-)-
morbidity, which underscores the importance of objective
assessment of GERD in these children.
Objective assessment of reflux using 24-h MII-pH
monitoring showed that LARS resulted in a significant
decrease in acidic and also weakly acidic reflux. An earlier
published pilot study by Loots et al. [8] did not show
significant reduction in weakly acidic reflux. However, in
this study only 10 patients were included, which may result
in a type II error. Weakly acidic reflux is often not suc-
cessfully treated by acid suppressive therapy (i.e., proton
pump inhibitors) as it only decreases the acidity of the
refluxate but does not treat the actual retrograde movement
of gastric content [40]. Furthermore, in young children
gastric content is buffered by frequent feeds and is there-
fore often not acidic.
LES resting and nadir pressure increased significantly
after LARS, which is in accordance with previous studies
on pediatric antireflux surgery [12, 36]. Increase in the
esophagogastric junction competence is expected, as it is
one of the mechanisms in which LARS prevents GERD
[41–43]. It has been reported that LARS may affect LES
relaxations and esophageal motility, thereby inducing
postoperative dysphagia [44]. In this current study, LARS
did, however, not affect LES relaxations and esophageal
motility.
Fig. 2 Effect of LARS on gastric emptying in patients with
preoperative delayed gastric emptying
Table 5 Predictors of the effect
of LARS on reflux reduction
Estimate p value 95 % CI
Age at time of operation -6.1 0.76 -47.2 to 34.9
Neurodevelopment 0.8 0.61 -2.7 to 4.4
Type of fundoplication 3.4 0.85 -33.8 to 40.6
Preoperative total number of reflux episodes 0.8 \0.0001 0.5 to 1.1
Preoperative gastric emptying -0.2 0.34 -0.6 to 0.2
Linear regression analysis (95 % CI 95 % confidence interval)
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In seven patients dysphagia was found after LARS.
New-onset dysphagia was seen in three of these patients
and was significantly more prevalent in NI children. Fur-
thermore, a nonsignificant trend was shown in favor of
Thal fundoplication (17 vs 57 %), compared to Nissen
fundoplication. New-onset dysphagia is thought to be
caused by fundoplication-induced restriction and postop-
erative swelling at the esophagogastric junction. LES
pressure testing in our cohort did show a significant
increase in LES resting and nadir pressure, which may
reflect this restriction. Complete (e.g., Nissen) and partial
(e.g., Thal and Toupet) fundoplications are all currently
used in the pediatric population, and reported dysphagia
rates differ between these techniques, but are mostly less
prominent after partial fundoplication [7, 15, 35]. Finally,
dysphagia may be a manifestation of GERD, as dysmotility
of the distal esophagus is frequently seen in adult patients
with esophagitis [45, 46].
In the current study, only one patient failed after LARS,
which made a logistic regression analysis for the identifi-
cation of predictors of LARS failure not possible. Rosen
et al. also used MII-pH monitoring trying to identify pre-
dictors for LARS failure using a Cox regression analysis;
however, their study was underpowered with only 37
patients and few failures and was not able to identify any
predictors [19]. Despite the fact that logistic regression was
not feasible, we still could perform a linear regression
analysis that identified that the number of preoperative
reflux episodes on MII-pH monitoring is a significant
determinant influencing the effect of LARS. Patients with a
higher number of reflux episodes on MII-pH monitoring
had significantly more reflux reduction after LARS. Age at
the time of operation, neurodevelopment and type of fun-
doplication did not show a significant effect. In the adult
literature, preoperative delayed GE negatively influenced
the success of LARS [45, 46]. In children with GERD,
delayed GE may influence the severity of GERD [47, 48].
Therefore, for this study we hypothesized that preoperative
delayed GE could be a risk factor for failure of LARS in
our pediatric cohort. In linear regression analysis, GE was,
however, not a significant predictor. LARS did signifi-
cantly improve GE in patients with preoperative delayed or
severely delayed GE, which has also been demonstrated in
adults [47, 48] and children [49] that have undergone
LARS.
One of the limitations of this current study was that we
enrolled fewer patients than anticipated. Although most
results on the efficacy of LARS showed statistically sig-
nificant differences, the number of included patients lim-
ited our linear regression analysis and therefore we were
only able to investigate five determinants assuming enough
statistical power with five included patients per chosen
predictor. As only one patient failed after LARS, a logistic
regression analysis to identify predictors of failure was not
possible. Furthermore, 3-month follow-up time may be too
short. As published in the previous study [9], reflux
symptoms may increase over time, and therefore, it is
important that we closely follow-up this current group over
the years.
In conclusion, LARS significantly reduces reflux com-
plaints, total AET and number of (acidic) reflux episodes in
children with therapy-resistant GERD. LES resting pres-
sure increases significantly after LARS, but esophageal
function was not affected by the procedure. GE signifi-
cantly improved in patients with preoperative delayed
gastric emptying, but in the overall group no differences
were observed. LARS showed better reflux reduction in
children with a higher number of reflux episodes on pre-
operative MII-pH monitoring. Identifying predictors for
failure was not possible due to the low failure rate of LARS
in this cohort at 3-month follow-up. Future studies should
entail multicenter prospective trials with a higher number
of patients and long-term follow-up to assess parameters in
predicting success of therapy.
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